Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals.

MLA

Giannini, Edoardo G., et al. “Improvement in Hepatitis C Virus Patients with Advanced, Compensated Liver Disease after Sustained Virological Response to Direct Acting Antivirals.” European Journal of Clinical Investigation, vol. 49, no. 3, Mar. 2019, p. e13056. EBSCOhost, https://doi.org/10.1111/eci.13056.

APA

Giannini, E. G., Crespi, M., Demarzo, M., Bodini, G., Furnari, M., Marabotto, E., Torre, F., Zentilin, P., & Savarino, V. (2019). Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals. European Journal of Clinical Investigation, 49(3), e13056. https://doi.org/10.1111/eci.13056

Chicago

Giannini, Edoardo G, Mattia Crespi, Mariagiulia Demarzo, Giorgia Bodini, Manuele Furnari, Elisa Marabotto, Francesco Torre, Patrizia Zentilin, and Vincenzo Savarino. 2019. “Improvement in Hepatitis C Virus Patients with Advanced, Compensated Liver Disease after Sustained Virological Response to Direct Acting Antivirals.” European Journal of Clinical Investigation 49 (3): e13056. doi:10.1111/eci.13056.